Hospitals in Switzerland compete with one another for patients.
Health Care
Review board’s new reference countries have more limited access to new and innovative drugs.
The original OHIP+ provided limited coverage to a population that largely didn’t need assistance.
Last year in B.C., the average wait time between referral to treatment was 26.6 weeks.
In Switzerland, the health-care system features managed competition among insurance companies and health-care providers.
In most countries with universal health care, patients share the cost of treatment—surgical or pharmaceutical.
The province will spend nearly $22 billion on health care in 2018/19.
Unlike Canadians, Germans do not face long wait times for health care.
Insurance companies are the principal beneficiaries of Ontario’s new publicly-funded pharmacare program.
Australia, Germany and the Netherlands all allow more private-sector involvement in health care than Canada.
Subscribe to the Fraser Institute
Get the latest news from the Fraser Institute on the latest research studies, news and events.



